Woodland DL: Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 2004, 25: 98-104. 10.1016/j.it.2003.11.009.
Article
CAS
PubMed
Google Scholar
McShane H, Brookes R, Gilbert S, Hill A: Enhanced immunogenicity of CD4 (+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun. 2001, 69: 681-686. 10.1128/IAI.69.2.681-686.2001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Koopman G, Mortier D, Hofman S, Niphuis H, Fagrouch Z, Norley S, Sutter G, Liljestrom P, Heeney JL: Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J Gen Virol. 2004, 85: 2915-2924. 10.1099/vir.0.80226-0.
Article
CAS
PubMed
Google Scholar
Matsui M, Moriya O, Akatsuka T: Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Vaccine. 2003, 21: 1629-1639. 10.1016/S0264-410X(02)00704-1.
Article
CAS
PubMed
Google Scholar
Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveckzy CJ, Ramshaw IA: Prime-boost immunization generates a high frequency, high-avidity CD8 (+) cytotoxic T lymphocyte population. Int Immunol. 2002, 14: 31-37. 10.1093/intimm/14.1.31.
Article
CAS
PubMed
Google Scholar
Vuola JM, Keating S, Webster DP, Berthoud T, Dunachie S, Gilbert SC, Hill AV: Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers. J Immunol. 2005, 174: 449-455.
Article
CAS
PubMed
Google Scholar
Garzon MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J: Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Vaccine. 2005, 23: 1384-1392. 10.1016/j.vaccine.2004.09.009.
Article
PubMed
Google Scholar
Meseda CA, Elkins KL, Merchlinsky MJ, Weir JP: Prime-Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus-2 Glycoprotein D Elicits Greater Specific Antibody and Cytokine Responses than DNA Vaccine Alone. The Journal of Infectious Diseases. 2002, 186: 1065-1073. 10.1086/344234.
Article
CAS
PubMed
Google Scholar
Timofeev AV, Kondrat'eva I, Karganova GG, Stephenson J: [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein]. Vopr Virusol. 2001, 46: 22-24.
CAS
PubMed
Google Scholar
Khoretonenko MV, Vorovitch MF, Zakharova LG, Pashvykina GV, Ovsyannikova NV, Stephenson JR, Timofeev AV, Altstein AD, Shneider AM: Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice. Immunol Lett. 2003, 90: 161-163. 10.1016/j.imlet.2003.09.002.
Article
CAS
PubMed
Google Scholar
Timofeev AV, Karganova GG: Tick-borne encephalitis vaccine: from past to future. 2003, Moscow: Pronto Prints Ltd
Google Scholar
Phillpotts RJ, Stephenson JR, Porterfield JS: Antibody-dependent enhancement of tick-borne encephalitis virus infection. J Gen Virol. 1985, 66: 1831-1837.
Article
PubMed
Google Scholar
Jacobs SC, Stephenson JR, Wilkinson GW: High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol. 1992, 66: 2086-2095.
PubMed Central
CAS
PubMed
Google Scholar
Rokitsky PF: Biological statistics. Vysshaya shkola. 1964, Minsk, USSR, (in Russian)
Google Scholar
Schlesinger JJ, Drandriss MW, Walsh EE: Protection against yellow fever 17D encephalitis in mice by passive transfer of monoclonal antibodies to the non-structural glycoprotein gp48 and by active immunization with gp48. J Immunol. 1985, 135: 2805-2809.
CAS
PubMed
Google Scholar
Timofeev AV, Ozherelkov SV, Pronin AV, Deeva AV, Karganova GG, Elbert LB, Stephenson JR: Immunological basis for protection in a murine modelof tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein. J Gen Virol. 1998, 79: 689-695.
Article
CAS
PubMed
Google Scholar
Mackett M, Smith GL, Moss B: Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A. 1982, 79: 7415-7419.
Article
PubMed Central
CAS
PubMed
Google Scholar
Altstein AD, Andzhaparidze OG, Antonova TP, Baev AA, Baisar D, Bendukidze KA: Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase. Dokl Akad Nauk SSSR. 1986, 289: 1493-1496. (in Russian)
Google Scholar
Chernos VI, Cheliapov NV, Antonova TP, Rakhilina LE, Unanov SS, Al'tshtein AD, Zakharova LG, Fodor II, Bendukidze KA, Komarov FI: Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers. Vopr Virusol. 1990, 35: 132-1355. (in Russian)
CAS
PubMed
Google Scholar
Altstein AD, Chernos VI: Poxvirus recombinants as potential vaccines. Concepts in Virology. Edited by: Mahy BWJ, Lvov DK. 1993, Switzerland, Harwood Academic Publisher, Chapter 35: 381-388.
Google Scholar
Buller RM, Smith GL, Cremer K, Notkins AL, Moss B: Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature. 1985, 317: 813-815. 10.1038/317813a0.
Article
CAS
PubMed
Google Scholar
Altstein AD, Zakharova LG, Loparev VN, Pashvykina GV, Gorodetsky SI, Chernos VI, Senkevich TG, Antonova TP, Andzhaparidze OG: Development of vaccinia virus recombinant on the basis LIVP strain inducing hepatitis B virus surface antigen. Dokl Akad Nauk SSSR. 1985, 285: 696-699. (in Russian)
Google Scholar
Stephenson JR, Crooks AJ, Lee JM: The synthesis of immunogenic polypeptides encoded by tick-borne encephalitis virus. J Gen Virol. 1987, 68: 1307-1316.
Article
CAS
PubMed
Google Scholar